$0.8740
0.1317.35%
Ult. Agg.: Nov 18, 10:04 AM

The average analyst price target for OS Therapies is $15.20, 1639.1% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $7 to $21. The latest change came on Jul 9, 2026, when Roth Capital initiated coverage of OS Therapies with a Buy rating and a $7 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months